Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of TS-091 in patients with narcolepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• TS-091

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Narcolepsy | Phase 2 | Status: COMPLETED